Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer
Clinical trial NCT03690739 · TERMINATED
Trial details
- NCT number
- NCT03690739
- Sponsor
- AGO Research GmbH
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-09
- Primary completion
- 2021-03-03
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.